Peptone is an innovative drug discovery company applying advanced biophysics, atomic-level experimental approaches, cutting-edge supercomputing and machine learning to the challenge of biopharmaceutical research and development. By bringing these proprietary approaches together, Peptone is exploring the world of intrinsically disordered proteins (IDPs) – proteins without a fixed structure that play a significant role in health and disease – opening up the possibility of novel therapeutics against this class of high value and previously undruggable targets.
Region: Europe
RhyGaze
RhyGaze is a cutting-edge biotechnology company based in Basel, Switzerland, and Philadelphia, Pa., USA, focused on developing gene therapies for retinal diseases causing blindness. Founded on pioneering research from the Institute of Molecular and Clinical Ophthalmology Basel (IOB), RhyGaze aims to restore vision and transform the lives of patients worldwide. IOB scientists Drs. Botond Roska, Bence György and Charles Gubser are the scientific founders of RhyGaze.
Wintermute
Wintermute is a global algorithmic liquidity provider for digital assets. Wintermute’s mission is to create liquid, efficient and transparent markets for institutional and retail investors across all vetted trading platforms and its own RFQ platform. Founded and managed by experienced traders and engineers from traditional financial markets, Wintermute brings the best practices of algorithmic and high-frequency trading into digital asset markets.
Kiln
Kiln is the leading enterprise-grade staking platform, enabling institutional customers to stake assets, and to whitelabel staking functionality into their offering. Kiln runs validators on all major PoS blockchains, with over $4b of crypto assets being programmatically staked and over 4% of the Ethereum network, running on a multi-cloud, multi-region infrastructure. Kiln also provides a validator-agnostic suite of products for fully automated deployment of validators, reporting and commission management, enabling custodians, wallets and exchanges to streamline staking operations across providers. Kiln is SOC2 Type 2 certified.
Ethena
Ethena is a digital finance company focused on providing innovative solutions within the cryptocurrency and blockchain sectors. The company offers services such as developing and managing stablecoins, which are cryptocurrencies pegged to traditional assets like the US dollar to minimize price volatility. Additionally, Ethena operates in the decentralized finance (DeFi) space, enabling users to participate in financial activities like lending, borrowing, and trading without traditional intermediaries through the use of smart contracts on blockchain networks. Ethena also provides tools for managing digital assets, helping users securely store, transfer, and utilize their cryptocurrencies with services like wallets and investment products. The company is committed to leveraging blockchain technology for its transparency, security, and efficiency, aiming to bridge the gap between traditional finance and the digital economy. Through these efforts, Ethena makes it easier for individuals and businesses to adopt and benefit from cryptocurrency technologies.
Coincover
Coincover provides a complete blockchain protection solution, addressing the most significant barrier to mainstream adoption: trust. Thier protection solutions ensure that access and assets are never lost. Today, Coincover helps over 350 of the biggest names in blockchain, including Fireblocks, BitGo, and Ledger, protect themselves and their customers from theft, hacking, and human error.
CLST
CLST (pronounced “Caeleste”) is the institutional communications venue to lend or borrow stablecoins and crypto assets, automating multi-dealer price negotiation and price matching for institutional lenders. CLST Markets integrates next generation features such as automated collateral management, counterparty risk assessments, interest rate benchmarking, blockchain-based electronic promissory notes and wallet connectivity for automated settlements. CLST aims to resolve market uncertainties and scaling issues in uncollateralized and collateralized lending and borrowing of stablecoins and crypto assets.
Asymmetry Finance
Asymmetry Finance is an innovative synthetic dollar protocol, delivering a yield-bearing stablecoin that aims to be both inflation-resistant and scalable enough to meet the demands of an exponentially growing market.
Amber Therapeutics
Amber Therapeutics is developing Amber-UI, a breakthrough adaptive neuromodulation therapy to treat women suffering with mixed urinary incontinence with the hope of transforming the clinical outcome and quality of life of a large untreated population. Amber-UI runs on the Company’s fully implantable Picostim system that targets the pudendal nerve to both stimulate and sense physiological responses. The therapy is configurable to the individual’s need and can respond dynamically to different events, adapting as needed between modes of operation. Amber’s technology platform is highly versatile and can be used to explore other novel therapy applications in both the pelvis and the broader nervous system, demonstrated by the work being carried out by the Company’s academic partnerships.
T-Therapeutics
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge. The company was created to harness the power of T cell biology, evolved over millions of years, to create safe and effective treatments for many cancers and autoimmune diseases.